Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor
Yanwei Li, Wei Zhou, Yang Li, et al.
Pharmacological Research (2020) Vol. 157, pp. 104833-104833
Open Access | Times Cited: 375

Showing 1-25 of 375 citing articles:

SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
Emma S. Winkler, Adam L. Bailey, Natasha M. Kafai, et al.
Nature Immunology (2020) Vol. 21, Iss. 11, pp. 1327-1335
Open Access | Times Cited: 917
Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections
Petra Zimmermann, Nigel Curtis
Archives of Disease in Childhood (2020) Vol. 106, Iss. 5, pp. 429-439
Open Access | Times Cited: 498
Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?
Varnica Bajaj, Nirupa Gadi, Allison P. Spihlman, et al.
Frontiers in Physiology (2021) Vol. 11
Open Access | Times Cited: 439
Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review)
Daniela Călina, Anca Oana Docea, Demetrios Petrakis, et al.
International Journal of Molecular Medicine (2020) Vol. 46, Iss. 1, pp. 3-16
Open Access | Times Cited: 318
K18-hACE2 mice develop respiratory disease resembling severe COVID-19
Claude Kwe Yinda, Julia R. Port, Trenton Bushmaker, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 1, pp. e1009195-e1009195
Open Access | Times Cited: 299
COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation
Duraisamy Kempuraj, Govindhasamy Pushpavathi Selvakumar, Mohammad Ejaz Ahmed, et al.
The Neuroscientist (2020) Vol. 26, Iss. 5-6, pp. 402-414
Open Access | Times Cited: 271
ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19
Donato Zipeto, Julys da Fonseca Palmeira, Gustavo Adolfo Arganãraz, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 244
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
Prasun K. Datta, Fengming Liu, Tracy Fischer, et al.
Theranostics (2020) Vol. 10, Iss. 16, pp. 7448-7464
Open Access | Times Cited: 243
Clinical characteristics and outcomes of cancer patients with COVID‐19
Fan Yang, Shaobo Shi, Jiling Zhu, et al.
Journal of Medical Virology (2020) Vol. 92, Iss. 10, pp. 2067-2073
Closed Access | Times Cited: 201
A snapshot of the Covid-19 pandemic among pregnant women in France
Gilles Kayem, E. Lecarpentier, Philippe Deruelle, et al.
Journal of Gynecology Obstetrics and Human Reproduction (2020) Vol. 49, Iss. 7, pp. 101826-101826
Open Access | Times Cited: 198
Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity
Wakako Sakaguchi, Nobuhisa Kubota, Tomoko Shimizu, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6000-6000
Open Access | Times Cited: 189
ACEI/ARB use and risk of infection or severity or mortality of COVID-19: A systematic review and meta-analysis
Xue Zhang, Jiong Yu, Li-ya Pan, et al.
Pharmacological Research (2020) Vol. 158, pp. 104927-104927
Open Access | Times Cited: 178
Controlling Cytokine Storm Is Vital in COVID-19
Lu Tang, Zhinan Yin, Yu Hu, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 173
Development of ACE2 autoantibodies after SARS-CoV-2 infection
John M. Arthur, J. Craig Forrest, Karl W. Boehme, et al.
PLoS ONE (2021) Vol. 16, Iss. 9, pp. e0257016-e0257016
Open Access | Times Cited: 167
Improving target assessment in biomedical research: the GOT-IT recommendations
Christoph H. Emmerich, Lorena Martinez‐Gamboa, M. Hofmann, et al.
Nature Reviews Drug Discovery (2020) Vol. 20, Iss. 1, pp. 64-81
Open Access | Times Cited: 154
The scRNA-seq Expression Profiling of the Receptor ACE2 and the Cellular Protease TMPRSS2 Reveals Human Organs Susceptible to SARS-CoV-2 Infection
Jing Qi, Yang Zhou, Jiao Hua, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 1, pp. 284-284
Open Access | Times Cited: 122
SARS-CoV-2 leads to a small vessel endotheliitis in the heart
Umberto Macciò, Annelies S. Zinkernagel, Srikanth Mairpady Shambat, et al.
EBioMedicine (2021) Vol. 63, pp. 103182-103182
Open Access | Times Cited: 110
Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases
Shen Wang, Bo Liang, Weiqi Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 97
Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China
Liyan Yang, Zhonglei Wang
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115503-115503
Open Access | Times Cited: 64
Seroprevalence of SARS-CoV-2 antibodies in children: a prospective multicentre cohort study
Thomas Waterfield, Chris Watson, Rebecca Moore, et al.
Archives of Disease in Childhood (2020) Vol. 106, Iss. 7, pp. 680-686
Open Access | Times Cited: 139
Human and novel coronavirus infections in children: a review
Nipunie Rajapakse, Devika Dixit
Paediatrics and International Child Health (2020) Vol. 41, Iss. 1, pp. 36-55
Closed Access | Times Cited: 132
Asthma among hospitalized patients with COVID-19 and related outcomes
Stephanie Lovinsky‐Desir, Deepti Deshpande, Aliva De, et al.
Journal of Allergy and Clinical Immunology (2020) Vol. 146, Iss. 5, pp. 1027-1034.e4
Open Access | Times Cited: 129
Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19
Pinky, Suchi Gupta, V. Krishnakumar, et al.
Stem Cell Reviews and Reports (2020) Vol. 17, Iss. 1, pp. 33-43
Open Access | Times Cited: 104
SARS-CoV-2 Infects Human Pluripotent Stem Cell-Derived Cardiomyocytes, Impairing Electrical and Mechanical Function
Silvia Marchianò, Tien-Ying Hsiang, Akshita Khanna, et al.
Stem Cell Reports (2021) Vol. 16, Iss. 3, pp. 478-492
Open Access | Times Cited: 101
The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions
Tapan Behl, Ishnoor Kaur, Simona Bungău, et al.
Life Sciences (2020) Vol. 257, pp. 118075-118075
Open Access | Times Cited: 100
Page 1 - Next Page

Scroll to top